The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
Zixiang Wang,1,* Chenyang Zhuang,1,* Weixin Chen,1 Zefang Li,2 Juan Li,1,3 Hong Lin,1,3 Dong Jian1 1Department of Orthopedics, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China; 2Department of Orthopedics, Qianjiang Central Hospital of Chongqing, Chon...
Main Authors: | Wang Z, Zhuang C, Chen W, Li Z, Li J, Lin H, Jian D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/the-effect-of-daily-teriparatide-versus-one-time-annually-zoledronic-a-peer-reviewed-fulltext-article-CIA |
Similar Items
-
Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
by: Yuta Tsubouchi, et al.
Published: (2018-10-01) -
Comparative Analysis of Open Transforaminal Lumbar Interbody Fusion and Wiltse Transforaminal Lumbar Interbody Fusion Approaches for Treating Single-Level Lumbar Spondylolisthesis: A Single-Center Retrospective Study
by: Renat Nurmukhametov, et al.
Published: (2023-11-01) -
Zoledronic acid and teriparatide have a complementary therapeutic effect on aseptic loosening in a rabbit model
by: Peng Wang, et al.
Published: (2021-06-01) -
Comparison of Intraoperative Endplate Injury between Mini-Open Lateral Lumbar Interbody Fusion (LLIF) and Transforaminal Lumbar Interbody Fusion (TLIF) and Analysis of Risk Factors: A Retrospective Study
by: Xiaowei Jing, et al.
Published: (2023-12-01) -
The Effects of Interbody Device Design and Placement on Lumbar Lordosis and Disc Height in Transforaminal Lumbar Interbody Fusion
by: Ian J. Wellington, et al.
Published: (2023-08-01)